FiteBac® Cavity Cleanser can not only remove debris in carious lesion preparations but can penetrate exposed dentin tubules allowing restorative adhesives to tightly bind to the prepared dentin surface while also helping to reduce the presence of dentally relevant microbes. Largent Health, LLC announced today a new FDA clearance to market the novel FiteBac® Antimicrobial…

Read More

The collaboration with Numab Therapeutics expands Boehringer Ingelheim’s bi- and multi-specific antibody pipeline with two front-runner projects in lung and gastrointestinal (GI) cancer and geographic atrophy (GA) Numab’s proprietary platform enables the engineering of first-in-class and best-in-class bi- and multi-specific antibodies in a true plug-and-play fashion Boehringer Ingelheim andNumab Therapeutics (Numab) today announced that they have…

Read More

Boehringer Ingelheim has opened a site in Shanghai to connect its R&D, business development and venture capital groups to Chinese drug developers. The site brings together all the units involved in the identification and support of promising drug development projects. With China’s domestic biotech scene blossoming, Boehringer has identified the country as a source of programs of…

Read More

Becton Dickinson & Co. won a U.S. regulator’s approval for a portable Covid-19 test that delivers results in 15 minutes. The Food and Drug Administration granted an emergency-use authorization for the BD Veritor Plus System, Franklin Lakes, New Jersey-based Becton Dickinson said Monday in a statement. The hand-held product, which is around the size of a mobile…

Read More

Dive Brief: FDA has granted emergency use authorization to a test from the Centers for Disease Control and Prevention designed to determine if a patient is infected with influenza or the novel coronavirus. The agency said Thursday the test will enable healthcare professionals to tell if respiratory symptoms are due to seasonal flu or COVID-19 using a single sample.…

Read More

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program, Project Lightspeed, against SARS-CoV-2, the virus causing the current global pandemic. The BNT162 program is evaluating at least four experimental vaccines, each of which represents a unique combination of mRNA…

Read More

Pfizer and Merck KGaA’s Bavencio has itself a leg up in the ultra-competitive bladder cancer market. Late Tuesday, the FDA greenlighted the drug in the so-called first-line maintenance setting for urothelial carcinoma patients who have completed an initial round of chemo and haven’t seen their disease progress. The verdict makes Bavencio the only med in the PD-1/PD-L1…

Read More

Gov. Brian Kemp on Monday extended the state’s public health emergency, certain business restrictions and his shelter-in-place order for the medically fragile amid a record spike in new cases of the coronavirus. The governor also announced Monday that he’s set to go on a statewide fly-around tour ahead of the July Fourth weekend to encourage Georgians to…

Read More